The Law of Compounding Medications And Drugs: Effective on July 1, 2015 to December 31, 2015, Centers for Medicare & Medicaid Services (CMS) required the use of Q9977 to identify any compounded drug including Avastin (bevacizumab, Genentech). Q9977 was supposed to take the place of J3490 and J3590, he said.

Monday, January 18, 2016

Effective on July 1, 2015 to December 31, 2015, Centers for Medicare & Medicaid Services (CMS) required the use of Q9977 to identify any compounded drug including Avastin (bevacizumab, Genentech). Q9977 was supposed to take the place of J3490 and J3590, he said.

http://www.healio.com/ophthalmology/regulatory-legislative/news/online/%7Babee7ec0-c53b-4204-8de0-6deb07c1918b%7D/corcoran-new-changes-in-the-2016-ophthalmic-practice-environment

No comments:

Subscribe to: Post Comments (Atom)